510(k) · Cleared
ClearedImmunocard Stat Campy, Model 751530
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Meridian Bioscience, Inc. · LQP Campylobacter Spp.
Cleared on May 28, 2009 as substantially equivalent to K982315 (Alexon - Trend, Inc., 1998) after a 72-day review. Its family tree reaches back 1 generation to 1998. 1 later device descends from it.
- Decided
- May 28, 2009
- Review
- 72 days
- Class
- Class I
- Product code
- LQP
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K982315 (1998). 1 later device descends from it, 1 citing it directly.
Most influential descendants
Showing 1 of 1 · See all- K173217Campylobacter Quik ChekTechlab, Inc. · 2018 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K982315 | Prospect Campylobacter Microplate Assay | Alexon - Trend, Inc. | 1998 | 1 |
| 0 (this device) | K090700 | Immunocard Stat Campy, Model 751530 | Meridian Bioscience, Inc. | 2009 | — |
| +1 | K173217 | Campylobacter Quik Chek | Techlab, Inc. | 2018 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2018 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LQP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LQP device
- #1 K210976 Curian Campyscore 2.6 · 1 generation · no Class I recall
- #2 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K982315 | Prospect Campylobacter Microplate AssaySummary page 1…apid immunochromatographic assay for Campylobacter Classification name: Cam pylobacter ssp. LOP, CFR section 866.311 0 Predicate device: K982315, ProSpecT Campylobacter EIA Reference comparator Bacterial culture Description of the ImmunoCard STAT! CAMPY is an immu… | 1998 |
| * | — | Premier CAMPY Named without a submission number |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K173217 | Campylobacter Quik Chek | 2018 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All LQP devicesLQP Campylobacter Spp.: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.
FDA decisions per year · LQP
2in 2021
2026 to Oct 25, outlined.
Median 510(k) review, days · LQP
Too few LQP 510(k)s in any year since 2007 to give a median.
Recalls per year · LQP
No recall names LQP since 2007.
Adverse event reports per year · LQP
No MAUDE report names LQP since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 2 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 2 | — | 0 | 0 |
| 2019 | 2 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 2 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
ImmunoCard STAT! CAMPY is an immunochromatographic rapid test for the qualitative detection of specific Campylobacter antigens in human stool. ImmunoCard STAT! CAMPY detects C. jejuni and C. coli in human stool, where stool may be either unpreserved or preserved in Cary-Blair-based transport media. Test results are to be used in conjunction with information available from the patient's clinical evaluation and other diagnostic procedures.
ImmunoCard STAT! CAMPY is not intended for point-of-care use. The device is intended for use in hospital, reference, regional, private or state laboratory settings.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K090700 · printed Nov 6, 2026
Cite this page
510(k) Report. “K090700: Immunocard Stat Campy, Model 751530.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K090700
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026